🔗 Share this article

As the United States proceeds with historic adjustments to its vaccination guidelines, an unexpected name appears unexpectedly: Tracy Beth Høeg, a Danish American sports physician and epidemiologist who rose to prominence by expressing skepticism about Covid vaccines in the pandemic and has zeroed in on potential deaths following COVID-19 immunization in her recent position at the US Food and Drug Administration (FDA).

Scheduled Overhauls to Childhood Immunization Program

Agency leaders planned to announce major changes to the childhood immunization program earlier this month, bringing the US with the Danish vaccine program, according to reports – a major change that would put the US out of alignment with a large portion of the world with no evidence for improved outcomes. The announcement has been delayed until the coming year.

In place of the top vaccines chief, Tracy Beth Høeg is scheduled to present at the event. She was just designated temporary leader of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth appointee to run the center this year.

A Shift at the Regulatory Body

This interim role may indicate a strengthened alliance between the drug and biologics divisions as Dr. Høeg and Dr. Prasad solidify control at the agency – and it points to a renewed priority upon dismantling already-approved immunizations at the FDA.

Høeg has frequently advocated for discontinuing some childhood vaccine recommendations in the US so as to align more similar to the Danish model, a nation with comprehensive healthcare and a number of inhabitants roughly the population of Wisconsin’s.

To date comments, she has persisted in emphasizing on vaccination policy – usually the purview of Dr. Prasad, head of the FDA’s vaccine center – instead of drug regulation.

Doubts Over Qualifications

Høeg has little discernible experience in medication creation, oversight or administrative roles, which has been customary for former heads of the CBER. She has served at the FDA as a top consultant to the agency head and CBER since March.

“She appears not to have the requisite experience” for overseeing the CDER, said Dr. Jonathan Howard. “She’s never run a randomized controlled trial. She is not versed in managing a large organization. She lacks background in drug approvals.”

Previous commissioners of CBER would “grasp laws and regulations and the science of medication creation”, said Dr. Janet Woodcock. “Clearly, she doesn’t have the kind of background that former directors who ran CBER have had.”

The drug center has an immense range of responsibilities at the FDA, Woodcock pointed out.

“Many people just focuses on the innovative therapies, but the generic program approves numerous generic drugs. There is also a biologic copycat branch, non-prescription drug unit and so forth, and every single one must be supervised,” Woodcock explained. “The thing you overlook, that is the part that I always told people is going to come back to haunt you.”

There is also, a major leadership element to the position, which oversees more than 5,000 personnel. “It is a massive leadership role, if you do it right,” Woodcock added.

Agency Reaction and Disputed Programs

Regarding concerns about Høeg’s fitness for the role and whether this appointment represents more teamwork among agency officials on immunizations, a representative responded that the “concerns are based on incorrect assumptions”.

“Her resume is consistent with the functions of her position,” the representative stated, noting the time Dr. Høeg spent advising the FDA commissioner on “medication safety and regulatory science, including predictive safety algorithms and vaccine surveillance”.

In her interim role, Dr. Høeg inherits the commissioner’s controversial expedited review system, a contentious rapid drug-approval program that allegedly worried her former heads. “How are these drugs being chosen for this fast-track system? Who makes the decisions?” Dr. Howard asked. “There is a lot of secrecy going on at the FDA right now.”

Broadly speaking, he stated, “the agency seems to be moving towards laxer regulations of pharmaceuticals, aside from shots.”

Documented Past Work on Vaccines

Concerning immunizations, Dr. Høeg has a more documented, if troubling, history, Howard said. She released a study using non-validated public submissions to assess the frequency of heart inflammation after COVID-19 immunization. She consulted for the Florida surgeon general Joseph Ladapo, who reportedly have altered data to imply Covid vaccines are more dangerous than they are.

Part of her “wish list” for the current administration included changing guidelines for recently developed shots and halting “unnecessary” immunizations, she remarked after the election on a audio program. At the agency, Høeg has reportedly proposed excluding teenage boys from receiving Covid vaccinations.

“She’s an all-around ideologue who begins with her preconceived notions and tailors the evidence to accommodate the evidence in a very deceptive, dishonest way,” Dr. Howard argued.

Gaining Influence and a “Campaign of Retribution”

Dr. Høeg joined fellow skeptics, {like|